COVID-19 Drug Treatment Concept

subject area of

• "2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": reply.  Journal Articles
• 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19  Journal Articles
• A living WHO guideline on drugs for covid-19  Journal Articles
• A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)  Journal Articles
• A real-time dashboard of clinical trials for COVID-19  Journal Articles
• Adherence of Clinical Practice Guidelines for Pharmacologic Treatments of Hospitalized Patients With COVID-19 to Trustworthy Standards  Journal Articles
• Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials  Journal Articles
• Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes  Journal Articles
• Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trial  Journal Articles
• Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis  Journal Articles
• Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT)  Journal Articles
• Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial  Journal Articles
• Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study  Journal Articles
• Choosing and accessing COVID-19 treatment options: a qualitative study with patients, caregivers, and health care providers in Lebanon  Journal Articles
• Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo  Journal Articles
• Clinical trials of disease stages in COVID 19: complicated and often misinterpreted  Journal Articles
• Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial  Journal Articles
• Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial  Journal Articles
• Core Outcomes Set for Trials in People With Coronavirus Disease 2019  Journal Articles
• Decavanadate interactions with the elements of the SARS-CoV-2 spike protein highlight the potential role of electrostatics in disrupting the infectivity cycle  Journal Articles
• Deep learning identifies synergistic drug combinations for treating COVID-19  Journal Articles
• Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments  Journal Articles
• Dexamethasone and remdesivir: finding method in the COVID-19 madness  Journal Articles
• Dexamethasone doses in patients with COVID‐19 and hypoxia: A systematic review and meta‐analysis  Journal Articles
• Diretrizes Brasileiras para o tratamento farmacológico de pacientes hospitalizados com COVID-19  Journal Articles
• Drug treatments for covid-19: living systematic review and network meta-analysis  Journal Articles
• Dysregulated light/dark cycle impairs sleep and delays the recovery of patients in intensive care units: A call for action for COVID-19 treatment  Journal Articles
• Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019  Journal Articles
• Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model  Journal Articles
• Early Treatment with Pegylated Interferon Lambda for Covid-19  Journal Articles
• Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs  Journal Articles
• Effect of Early Treatment with Ivermectin among Patients with Covid-19  Journal Articles
• Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial  Journal Articles
• Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial  Journal Articles
• Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial.  Journal Articles
• Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial  Journal Articles
• Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials  Journal Articles
• Efficacité et innocuité des agents antiviraux contre le SRAS-CoV-2, selon des données d’études sur la COVID-19 et d’autres infections virales aiguës : revue systématique et méta-analyse  Journal Articles
• Efficacité et innocuité des corticostéroïdes dans le traitement de la COVID-19 selon des données pour la COVID-19, d’autres infections aux coronavirus, l’influenza, la pneumonie extrahospitalière et le syndrome de détresse respiratoire aiguë : revue systématique et méta-analyse  Journal Articles
• Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis  Journal Articles
• Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial  Journal Articles
• Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial  Journal Articles
• Ending COVID-19: progress and gaps in research—highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings  Journal Articles
• Fluvoxamine for the treatment of COVID-19 – Author's reply  Journal Articles
• Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH  Journal Articles
• Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society  Journal Articles
• Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study  Journal Articles
• Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19  Journal Articles
• Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials  Journal Articles
• Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19  Journal Articles
• In COVID-19, tocilizumab reduces all-cause mortality at 28 d  Journal Articles
• In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival  Journal Articles
• In high-risk outpatients with COVID-19, remdesivir reduced COVID-19–related hospitalization or all-cause death at 28 d  Journal Articles
• In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir–ritonavir improved outcomes  Journal Articles
• In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d  Journal Articles
• Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)  Journal Articles
• Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial  Journal Articles
• Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial  Journal Articles
• International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019  Journal Articles
• Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)  Journal Articles
• Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project)  Journal Articles
• Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review  Journal Articles
• Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group  Journal Articles
• Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel  Journal Articles
• Lessons learned from COVID-19 for the post-antibiotic future  Journal Articles
• Managing drug shortages during a pandemic: tocilizumab and COVID-19  Journal Articles
• Matched vs Nonmatched Placebos in a Randomized Trial of COVID-19 Treatments  Journal Articles
• My Kingdom for a Denominator, or at Least Enough Data  Journal Articles
• One Solution for All: Searching for Universal Aptamers for Constantly Mutating Spike Proteins of SARS‐CoV‐2  Journal Articles
• Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19  Journal Articles
• Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1)  Journal Articles
• Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial  Journal Articles
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Journal Articles
• Possible Application of Melatonin in Long COVID  Journal Articles
• Pregnancy and COVID‐19: pharmacologic considerations  Journal Articles
• Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD  Journal Articles
• Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19  Journal Articles
• Remdesivir for severe covid-19: a clinical practice guideline  Journal Articles
• Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial  Journal Articles
• Remdésivir chez les patients hospitalisés pour la COVID-19 au Canada: essai clinique randomisé et contrôlé  Journal Articles
• Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial  Journal Articles
• Short- and long-term effects of imatinib in hospitalised COVID-19 patients: A randomised trial  Journal Articles
• Shortages of Palliative Care Medications in Canada during the COVID-19 Pandemic: Gambling with Suffering  Journal Articles
• Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1)  Journal Articles
• Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1)  Journal Articles
• Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)  Journal Articles
• Stroke and Thromboprophylaxis in the Era of COVID-19  Journal Articles
• Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions  Journal Articles
• The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19  Journal Articles
• The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study  Journal Articles
• The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials  Journal Articles
• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19  Journal Articles
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19  Journal Articles
• Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19  Journal Articles
• Tocilizumab versus the Covid19 tempest: All’s well that ends well or much ado about nothing?  Journal Articles
• Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial  Journal Articles
• Trials and tribulations: so many potential treatments, so few answers  Journal Articles
• Twenty articles that critical care clinicians should read about COVID-19  Journal Articles
• Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)  Journal Articles
• Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation  Journal Articles
• Venous Thromboembolism in COVID-19  Journal Articles
• Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?  Journal Articles